Overview
Mohammad Pazooki is a Hematologist Oncology specialist and a Hematologist in Manchester, Connecticut. Dr. Pazooki is rated as an Experienced provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Gliosarcoma, Embryonal Tumor with Multilayered Rosettes, and Bone Marrow Aspiration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Haynes St, Fl 2, Manchester, CT 06040
Baystate Medical Practices Inc
John Mccann is a Hematologist and a Hematologist Oncology provider in Springfield, Massachusetts. Dr. Mccann is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC). Dr. Mccann is currently accepting new patients.
Azadeh Namakydoust is a Hematologist and an Oncologist in Farmington, Connecticut. Dr. Namakydoust is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma.
The Hospital Of Central Connecticut At New Britain General And Bradley
Krishna Gunturu is a Hematologist Oncology specialist and a Hematologist in New Britain, Connecticut. Dr. Gunturu is rated as a Distinguished provider by MediFind in the treatment of ALK-Positive Non-Small Cell Lung Cancer. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), ALK-Positive Non-Small Cell Lung Cancer, Squamous Cell Lung Carcinoma, and Liver Embolization.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Pazooki isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Pazooki isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Acute Mountain SicknessDr. Pazooki isAdvanced. Learn about Acute Mountain Sickness.
- AgranulocytosisDr. Pazooki isAdvanced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Pazooki isAdvanced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- AnemiaDr. Pazooki isAdvanced. Learn about Anemia.
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Pazooki isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Arterial Occlusion of KidneyDr. Pazooki isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Eosinophilic PneumoniaDr. Pazooki isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Pazooki isExperienced. Learn about Acute Myeloid Leukemia (AML).